Skip to Content

Find Comparable ETFs for First Trust NYSE Arca Biotechnology Index Fund

First Trust NYSE Arca Biotechnology Index Fund

FBT - PCX
ETF Category
Health & Biotech Equities
Asset Class
Equity
AUM
$1,178M
Expense Ratio
0.56% (Moderate)
Trading Volume
28.0K (Low)
Issuer
First Trust
Number of Holdings
31
Inception Date
2006-06-19 (18 years)
Momentum
Very Weak Neutral Very Strong
AUM
Micro Medium Very Large
Concentration
Very Low High Very High
Volatility
Very Low Low Very High
Overview
Momentum
Concentration
ESG
P/E Ratio
17.55
Annual Dividend Rate
0.00%
Beta
0.79
50-Day Moving Average
$174.15
Price vs. 50-Day MA
-0.39%
200-Day Moving Average
$167.51
Price vs. 200-Day MA
3.56%
1 Year Fund Flow
-$306M (-26% of AUM)
3 Year Fund Flow
-$646M (-55% of AUM)
5 Year Fund Flow
-$1,855M (-158% of AUM)
% in Top 10 Holdings (Market Cap Weighted)
36.62%
% in Top 15 Holdings (Market Cap Weighted)
53.32%
% in Top 50 Holdings (Market Cap Weighted)
99.99%
ESG Score
6.1300
ESG Peer %
37.59
ESG Global %
40.26
Carbon Intensity (Tons CO2e/$M Sales)
28
ESG Exclusion %
0.00
Sustainable Impact %
40.27

iShares Biotechnology ETF

IBB - NGM
View IBB's Comps
A+
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Health & Biotech Equities
Equity
AUM: $7,909M
Expense Ratio: 0.45% (Moderate)
Volume: 572.9K (Moderate)
Issuer: BlackRock, Inc.
Holdings: 211
Inception: 2001-02-05 (24 years)
Weak Momentum
Medium AUM
Very Low Concentration
Moderate Volatility
Compare
Overview
Momentum
Concent.
ESG

correlation
A+

correlation

Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 93%

R-squared: 86%

This indicates a strong positive relationship between the price movements of these assets.

network
A+

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 7
  • FBT in IBB's comparables: Yes
  • IBB in FBT's comparables: Yes

A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

valuation
A+

valuation

Compares valuation metrics to assess if the assets are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.

  • P/E Ratio: 17.55 vs 15.68

A high score indicates that the market values these assets similarly relative to their financials, suggesting comparable growth expectations and risk profiles.

volatility
A+

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • FBT Beta: 0.79 (Low)
  • IBB Beta: 0.84 (Low)
  • FBT 200-day Volatility: 14.96%
  • IBB 200-day Volatility: 15.85%

A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • FBT Price vs 200-day MA: 104%
  • IBB Price vs 200-day MA: 97%

Performance Comparison:

Period FBT IBB
Year_1 9% 14%
Year_3 0% -4%
Year_5 4% 7%

A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

geo
A+

geo

Evaluates the geographical similarity of the assets based on country, currency, and exchange.

  • Currency: USD vs USD
  • Exchange: PCX vs NGM

A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

sector
A+

sector

Compares the sector, industry, and other classifications of both assets.

  • ETF Category: Health & Biotech Equities vs Health & Biotech Equities

A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.

Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.

dividend
A+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • FBT Dividend Yield: 0%
  • IBB Dividend Yield: 0%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

P/E Ratio
15.68
Annual Dividend Rate
0.28%
Beta
0.84
50-Day Moving Average
$135.89
Price vs. 50-Day MA
-0.01%
200-Day Moving Average
$140.48
Price vs. 200-Day MA
-3.27%
1 Year Fund Flow
-$566M (-7% of AUM)
3 Year Fund Flow
-$1,391M (-18% of AUM)
5 Year Fund Flow
-$1,540M (-19% of AUM)
% in Top 10 Holdings
51%
% in Top 15 Holdings
60%
% in Top 50 Holdings
85%
ESG Score
6.7800
ESG Peer %
68.42
ESG Global %
60.65
Carbon Intensity
22
ESG Exclusion %
0.00
Sustainable Impact %
33.73

SPDR S&P Biotech ETF

XBI - PCX
View XBI's Comps
A+
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Health & Biotech Equities
Equity
AUM: $7,837M
Expense Ratio: 0.35% (Very Low)
Volume: 7.2M (High)
Issuer: State Street
Holdings: 140
Inception: 2006-01-31 (19 years)
Weak Momentum
Medium AUM
Low Concentration
High Volatility
Compare
Overview
Momentum
Concent.
ESG

correlation
A+

correlation

Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 85%

R-squared: 73%

This indicates a strong positive relationship between the price movements of these assets.

network
A+

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 6
  • FBT in XBI's comparables: Yes
  • XBI in FBT's comparables: Yes

A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

valuation
A+

valuation

Compares valuation metrics to assess if the assets are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.

  • P/E Ratio: 17.55 vs 17.88

A high score indicates that the market values these assets similarly relative to their financials, suggesting comparable growth expectations and risk profiles.

volatility
A

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • FBT Beta: 0.79 (Low)
  • XBI Beta: 0.97 (Average)
  • FBT 200-day Volatility: 14.96%
  • XBI 200-day Volatility: 23.88%

A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • FBT Price vs 200-day MA: 104%
  • XBI Price vs 200-day MA: 91%

Performance Comparison:

Period FBT XBI
Year_1 9% 19%
Year_3 0% -8%
Year_5 4% 2%

A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

geo
A+

geo

Evaluates the geographical similarity of the assets based on country, currency, and exchange.

  • Currency: USD vs USD
  • Exchange: PCX vs PCX

A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

sector
A+

sector

Compares the sector, industry, and other classifications of both assets.

  • ETF Category: Health & Biotech Equities vs Health & Biotech Equities

A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.

Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.

dividend
A+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • FBT Dividend Yield: 0%
  • XBI Dividend Yield: 0%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

P/E Ratio
17.88
Annual Dividend Rate
0.13%
Beta
0.97
50-Day Moving Average
$90.74
Price vs. 50-Day MA
-4.31%
200-Day Moving Average
$95.25
Price vs. 200-Day MA
-8.84%
1 Year Fund Flow
$133M (2% of AUM)
3 Year Fund Flow
$2,495M (32% of AUM)
5 Year Fund Flow
$3,332M (43% of AUM)
% in Top 10 Holdings
27%
% in Top 15 Holdings
39%
% in Top 50 Holdings
75%
ESG Score
5.4800
ESG Peer %
23.50
ESG Global %
29.39
Carbon Intensity
37
ESG Exclusion %
0.00
Sustainable Impact %
29.00

Invesco Pharmaceuticals ETF

PJP - PCX
View PJP's Comps
A+
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Health & Biotech Equities
Equity
AUM: $285M
Expense Ratio: 0.56% (Moderate)
Volume: 8.7K (Very Low)
Issuer: Invesco
Holdings: 23
Inception: 2005-06-23 (19 years)
Neutral Momentum
Small AUM
Moderate Concentration
Low Volatility
Compare
Overview
Momentum
Concent.
ESG

correlation
A+

correlation

Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 74%

R-squared: 55%

This indicates a strong positive relationship between the price movements of these assets.

network
A+

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 2
  • FBT in PJP's comparables: Yes
  • PJP in FBT's comparables: No

A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

valuation
A+

valuation

Compares valuation metrics to assess if the assets are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.

  • P/E Ratio: 17.55 vs 17.24

A high score indicates that the market values these assets similarly relative to their financials, suggesting comparable growth expectations and risk profiles.

volatility
A

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • FBT Beta: 0.79 (Low)
  • PJP Beta: 0.66 (Low)
  • FBT 200-day Volatility: 14.96%
  • PJP 200-day Volatility: 11.88%

A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • FBT Price vs 200-day MA: 104%
  • PJP Price vs 200-day MA: 102%

Performance Comparison:

Period FBT PJP
Year_1 9% 10%
Year_3 0% 3%
Year_5 4% 9%

A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

geo
A+

geo

Evaluates the geographical similarity of the assets based on country, currency, and exchange.

  • Currency: USD vs USD
  • Exchange: PCX vs PCX

A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

sector
A+

sector

Compares the sector, industry, and other classifications of both assets.

  • ETF Category: Health & Biotech Equities vs Health & Biotech Equities

A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.

Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.

dividend
A+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • FBT Dividend Yield: 0%
  • PJP Dividend Yield: 1%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

P/E Ratio
17.24
Annual Dividend Rate
0.89%
Beta
0.66
50-Day Moving Average
$84.95
Price vs. 50-Day MA
1.86%
200-Day Moving Average
$85.05
Price vs. 200-Day MA
1.74%
1 Year Fund Flow
-$35M (-12% of AUM)
3 Year Fund Flow
-$168M (-59% of AUM)
5 Year Fund Flow
-$234M (-82% of AUM)
% in Top 10 Holdings
56%
% in Top 15 Holdings
77%
% in Top 50 Holdings
100%
ESG Score
5.7000
ESG Peer %
27.26
ESG Global %
32.37
Carbon Intensity
32
ESG Exclusion %
0.00
Sustainable Impact %
27.29

Invesco Biotechnology & Genome ETF

PBE - PCX
View PBE's Comps
A+
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Health & Biotech Equities
Equity
AUM: $270M
Expense Ratio: 0.58% (Moderate)
Volume: 11.6K (Low)
Issuer: Invesco
Holdings: 32
Inception: 2005-06-23 (19 years)
Weak Momentum
Small AUM
High Concentration
Moderate Volatility
Compare
Overview
Momentum
Concent.
ESG

The First Trust NYSE Arca Biotechnology ETF includes a diversified selection of biotech stocks, similar to PBE's strategy of investing in biotech equities.

correlation
A+

correlation

Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 87%

R-squared: 76%

This indicates a strong positive relationship between the price movements of these assets.

network
A+

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 6
  • FBT in PBE's comparables: Yes
  • PBE in FBT's comparables: Yes

A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

volatility
A

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • FBT Beta: 0.79 (Low)
  • PBE Beta: 0.87 (Average)
  • FBT 200-day Volatility: 14.96%
  • PBE 200-day Volatility: 16.22%

A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • FBT Price vs 200-day MA: 104%
  • PBE Price vs 200-day MA: 96%

Performance Comparison:

Period FBT PBE
Year_1 9% 12%
Year_3 0% -3%
Year_5 4% 5%

A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

geo
A+

geo

Evaluates the geographical similarity of the assets based on country, currency, and exchange.

  • Currency: USD vs USD
  • Exchange: PCX vs PCX

A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

sector
A+

sector

Compares the sector, industry, and other classifications of both assets.

  • ETF Category: Health & Biotech Equities vs Health & Biotech Equities

A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.

Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.

dividend
A+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • FBT Dividend Yield: 0%
  • PBE Dividend Yield: 0%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

P/E Ratio
118.60
Annual Dividend Rate
0.05%
Beta
0.87
50-Day Moving Average
$67.88
Price vs. 50-Day MA
-3.26%
200-Day Moving Average
$68.19
Price vs. 200-Day MA
-3.70%
1 Year Fund Flow
-$9M (-3% of AUM)
3 Year Fund Flow
-$6M (-2% of AUM)
5 Year Fund Flow
-$39M (-14% of AUM)
% in Top 10 Holdings
48%
% in Top 15 Holdings
63%
% in Top 50 Holdings
100%
ESG Score
5.5100
ESG Peer %
23.87
ESG Global %
29.76
Carbon Intensity
31
ESG Exclusion %
0.00
Sustainable Impact %
43.96

ALPS Medical Breakthroughs ETF

SBIO - PCX
View SBIO's Comps
A+
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Health & Biotech Equities
Equity
AUM: $116M
Expense Ratio: 0.50% (Moderate)
Volume: 11.6K (Low)
Issuer: SS&C
Holdings: 102
Inception: 2014-12-30 (10 years)
Weak Momentum
Small AUM
Very High Concentration
High Volatility
Compare
Overview
Momentum
Concent.
ESG

correlation
A+

correlation

Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 70%

R-squared: 49%

This indicates a moderate positive relationship between the price movements of these assets.

network
A+

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 6
  • FBT in SBIO's comparables: No
  • SBIO in FBT's comparables: Yes

A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

volatility
A

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • FBT Beta: 0.79 (Low)
  • SBIO Beta: 0.92 (Average)
  • FBT 200-day Volatility: 14.96%
  • SBIO 200-day Volatility: 27.48%

A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • FBT Price vs 200-day MA: 104%
  • SBIO Price vs 200-day MA: 86%

Performance Comparison:

Period FBT SBIO
Year_1 9% 14%
Year_3 0% -7%
Year_5 4% 0%

A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

geo
A+

geo

Evaluates the geographical similarity of the assets based on country, currency, and exchange.

  • Currency: USD vs USD
  • Exchange: PCX vs PCX

A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

sector
A+

sector

Compares the sector, industry, and other classifications of both assets.

  • ETF Category: Health & Biotech Equities vs Health & Biotech Equities

A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.

Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.

dividend
A+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • FBT Dividend Yield: 0%
  • SBIO Dividend Yield: -1%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

P/E Ratio
N/A
Annual Dividend Rate
0.19%
Beta
0.92
50-Day Moving Average
$32.36
Price vs. 50-Day MA
-5.04%
200-Day Moving Average
$35.54
Price vs. 200-Day MA
-13.53%
1 Year Fund Flow
-$9M (-8% of AUM)
3 Year Fund Flow
-$53M (-46% of AUM)
5 Year Fund Flow
-$58M (-50% of AUM)
% in Top 10 Holdings
27%
% in Top 15 Holdings
38%
% in Top 50 Holdings
80%
ESG Score
5.3000
ESG Peer %
21.43
ESG Global %
27.18
Carbon Intensity
52
ESG Exclusion %
0.00
Sustainable Impact %
8.43

iShares Russell 1000 ETF

IWB - PCX
View IWB's Comps
A
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Large Cap Growth Equities
Equity
AUM: $36,501M
Expense Ratio: 0.15% (Low)
Volume: 977.7K (Moderate)
Issuer: BlackRock, Inc.
Holdings: 1013
Inception: 2000-05-15 (24 years)
Neutral Momentum
Large AUM
Very Low Concentration
Low Volatility
Compare
Overview
Momentum
Concent.
ESG

correlation
A

correlation

Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 55%

R-squared: 30%

This indicates a moderate positive relationship between the price movements of these assets.

network
B

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 0
  • FBT in IWB's comparables: No
  • IWB in FBT's comparables: No

A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

valuation
A+

valuation

Compares valuation metrics to assess if the assets are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.

  • P/E Ratio: 17.55 vs 19.16

A high score indicates that the market values these assets similarly relative to their financials, suggesting comparable growth expectations and risk profiles.

volatility
A

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • FBT Beta: 0.79 (Low)
  • IWB Beta: 1.01 (Average)
  • FBT 200-day Volatility: 14.96%
  • IWB 200-day Volatility: 11.71%

A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • FBT Price vs 200-day MA: 104%
  • IWB Price vs 200-day MA: 102%

Performance Comparison:

Period FBT IWB
Year_1 9% 20%
Year_3 0% 7%
Year_5 4% 14%

A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

geo
A+

geo

Evaluates the geographical similarity of the assets based on country, currency, and exchange.

  • Currency: USD vs USD
  • Exchange: PCX vs PCX

A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

sector
B+

sector

Compares the sector, industry, and other classifications of both assets.

  • ETF Category: Health & Biotech Equities vs Large Cap Growth Equities

A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.

Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.

dividend
A+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • FBT Dividend Yield: 0%
  • IWB Dividend Yield: 1%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

P/E Ratio
19.16
Annual Dividend Rate
1.20%
Beta
1.01
50-Day Moving Average
$328.66
Price vs. 50-Day MA
-2.54%
200-Day Moving Average
$313.61
Price vs. 200-Day MA
2.13%
1 Year Fund Flow
-$1,343M (-4% of AUM)
3 Year Fund Flow
-$1,037M (-3% of AUM)
5 Year Fund Flow
-$1,707M (-5% of AUM)
% in Top 10 Holdings
31%
% in Top 15 Holdings
37%
% in Top 50 Holdings
53%
ESG Score
6.6500
ESG Peer %
35.99
ESG Global %
54.42
Carbon Intensity
93
ESG Exclusion %
10.15
Sustainable Impact %
7.59

SPDR S&P 500 ETF Trust

SPY - PCX
View SPY's Comps
A
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Large Cap Growth Equities
Equity
AUM: $557,214M
Expense Ratio: 0.09% (Low)
Volume: 75.5M (Very High)
Issuer: State Street
Holdings: 504
Inception: 1993-01-22 (32 years)
Neutral Momentum
Very Large AUM
Low Concentration
Low Volatility
Compare
Overview
Momentum
Concent.
ESG

correlation
A

correlation

Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 52%

R-squared: 27%

This indicates a moderate positive relationship between the price movements of these assets.

network
B

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 0
  • FBT in SPY's comparables: No
  • SPY in FBT's comparables: No

A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

valuation
A+

valuation

Compares valuation metrics to assess if the assets are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.

  • P/E Ratio: 17.55 vs 17.86

A high score indicates that the market values these assets similarly relative to their financials, suggesting comparable growth expectations and risk profiles.

volatility
A

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • FBT Beta: 0.79 (Low)
  • SPY Beta: 1.00 (Average)
  • FBT 200-day Volatility: 14.96%
  • SPY 200-day Volatility: 11.69%

A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • FBT Price vs 200-day MA: 104%
  • SPY Price vs 200-day MA: 104%

Performance Comparison:

Period FBT SPY
Year_1 9% 20%
Year_3 0% 8%
Year_5 4% 14%

A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

geo
A+

geo

Evaluates the geographical similarity of the assets based on country, currency, and exchange.

  • Currency: USD vs USD
  • Exchange: PCX vs PCX

A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

sector
B+

sector

Compares the sector, industry, and other classifications of both assets.

  • ETF Category: Health & Biotech Equities vs Large Cap Growth Equities

A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.

Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.

dividend
A+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • FBT Dividend Yield: 0%
  • SPY Dividend Yield: 1%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

P/E Ratio
17.86
Annual Dividend Rate
1.26%
Beta
1.00
50-Day Moving Average
$598.02
Price vs. 50-Day MA
-0.64%
200-Day Moving Average
$570.72
Price vs. 200-Day MA
4.11%
1 Year Fund Flow
$33,622M (6% of AUM)
3 Year Fund Flow
$60,638M (11% of AUM)
5 Year Fund Flow
$45,285M (8% of AUM)
% in Top 10 Holdings
34%
% in Top 15 Holdings
40%
% in Top 50 Holdings
58%
ESG Score
6.7100
ESG Peer %
53.88
ESG Global %
58.00
Carbon Intensity
94
ESG Exclusion %
10.68
Sustainable Impact %
7.87

iShares MSCI Global Metals & Mining Producers ETF

PICK - BTS
View PICK's Comps
B+
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Materials
Equity
AUM: $1,039M
Expense Ratio: 0.39% (Low)
Volume: 219.8K (Moderate)
Issuer: BlackRock, Inc.
Holdings: 259
Inception: 2012-01-31 (13 years)
Weak Momentum
Medium AUM
Very Low Concentration
Moderate Volatility
Compare
Overview
Momentum
Concent.
ESG

correlation
B+

correlation

Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 34%

R-squared: 12%

This indicates a weak positive relationship between the price movements of these assets.

network
B

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 0
  • FBT in PICK's comparables: No
  • PICK in FBT's comparables: No

A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

valuation
A+

valuation

Compares valuation metrics to assess if the assets are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.

  • P/E Ratio: 17.55 vs 6.34

A high score indicates that the market values these assets similarly relative to their financials, suggesting comparable growth expectations and risk profiles.

volatility
A+

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • FBT Beta: 0.79 (Low)
  • PICK Beta: 1.18 (Average)
  • FBT 200-day Volatility: 14.96%
  • PICK 200-day Volatility: 20.21%

A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • FBT Price vs 200-day MA: 104%
  • PICK Price vs 200-day MA: 95%

Performance Comparison:

Period FBT PICK
Year_1 9% -5%
Year_3 0% -2%
Year_5 4% 12%

A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

geo
A+

geo

Evaluates the geographical similarity of the assets based on country, currency, and exchange.

  • Currency: USD vs USD
  • Exchange: PCX vs BTS

A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

sector
C+

sector

Compares the sector, industry, and other classifications of both assets.

  • ETF Category: Health & Biotech Equities vs Materials

A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.

Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.

dividend
C+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • FBT Dividend Yield: 0%
  • PICK Dividend Yield: 4%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

P/E Ratio
6.34
Annual Dividend Rate
3.91%
Beta
1.18
50-Day Moving Average
$35.96
Price vs. 50-Day MA
3.62%
200-Day Moving Average
$39.30
Price vs. 200-Day MA
-5.19%
1 Year Fund Flow
-$472M (-45% of AUM)
3 Year Fund Flow
$59M (6% of AUM)
5 Year Fund Flow
$852M (82% of AUM)
% in Top 10 Holdings
49%
% in Top 15 Holdings
58%
% in Top 50 Holdings
82%
ESG Score
5.9300
ESG Peer %
53.33
ESG Global %
36.58
Carbon Intensity
594
ESG Exclusion %
13.83
Sustainable Impact %
0.85
Toggle between similar ETFs and stocks for comparison.

Loading comparable ETFs ...

iShares Biotechnology ETF

IBB - NGM
A+
$135.88 -0.91 (-0.67%)
Health & Biotech Equities
Equity
AUM: $7,909M
Expense Ratio: 0.45% (Moderate)
Volume: 572.9K (Moderate)
Issuer: BlackRock, Inc.
Holdings: 211
Inception: 2001-02-05 (24 years)
Weak Momentum
Medium AUM
Very Low Concentration
Moderate Volatility

SPDR S&P Biotech ETF

XBI - PCX
A+
$86.83 -0.99 (-1.13%)
Health & Biotech Equities
Equity
AUM: $7,837M
Expense Ratio: 0.35% (Very Low)
Volume: 7.2M (High)
Issuer: State Street
Holdings: 140
Inception: 2006-01-31 (19 years)
Weak Momentum
Medium AUM
Low Concentration
High Volatility

Invesco Pharmaceuticals ETF

PJP - PCX
A+
$86.53 +0.54 (0.63%)
Health & Biotech Equities
Equity
AUM: $285M
Expense Ratio: 0.56% (Moderate)
Volume: 8.7K (Very Low)
Issuer: Invesco
Holdings: 23
Inception: 2005-06-23 (19 years)
Neutral Momentum
Small AUM
Moderate Concentration
Low Volatility

Invesco Biotechnology & Genome ETF

PBE - PCX
A+
$65.67 +0.14 (0.21%)
Health & Biotech Equities
Equity
AUM: $270M
Expense Ratio: 0.58% (Moderate)
Volume: 11.6K (Low)
Issuer: Invesco
Holdings: 32
Inception: 2005-06-23 (19 years)
Weak Momentum
Small AUM
High Concentration
Moderate Volatility

ALPS Medical Breakthroughs ETF

SBIO - PCX
A+
$30.73 -0.10 (-0.32%)
Health & Biotech Equities
Equity
AUM: $116M
Expense Ratio: 0.50% (Moderate)
Volume: 11.6K (Low)
Issuer: SS&C
Holdings: 102
Inception: 2014-12-30 (10 years)
Weak Momentum
Small AUM
Very High Concentration
High Volatility

iShares Russell 1000 ETF

IWB - PCX
A
$320.30 +3.63 (1.15%)
Large Cap Growth Equities
Equity
AUM: $36,501M
Expense Ratio: 0.15% (Low)
Volume: 977.7K (Moderate)
Issuer: BlackRock, Inc.
Holdings: 1013
Inception: 2000-05-15 (24 years)
Neutral Momentum
Large AUM
Very Low Concentration
Low Volatility

SPDR S&P 500 ETF Trust

SPY - PCX
A
$594.18 +9.13 (1.56%)
Large Cap Growth Equities
Equity
AUM: $557,214M
Expense Ratio: 0.09% (Low)
Volume: 75.5M (Very High)
Issuer: State Street
Holdings: 504
Inception: 1993-01-22 (32 years)
Neutral Momentum
Very Large AUM
Low Concentration
Low Volatility

iShares MSCI Global Metals & Mining Producers ETF

PICK - BTS
B+
$37.26 +1.65 (4.63%)
Materials
Equity
AUM: $1,039M
Expense Ratio: 0.39% (Low)
Volume: 219.8K (Moderate)
Issuer: BlackRock, Inc.
Holdings: 259
Inception: 2012-01-31 (13 years)
Weak Momentum
Medium AUM
Very Low Concentration
Moderate Volatility